395 related articles for article (PubMed ID: 11134431)
1. A randomized trial of granulocyte-macrophage colony-stimulating factor in neonates with sepsis and neutropenia.
Bilgin K; Yaramiş A; Haspolat K; Taş MA; Günbey S; Derman O
Pediatrics; 2001 Jan; 107(1):36-41. PubMed ID: 11134431
[TBL] [Abstract][Full Text] [Related]
2. Human granulocyte colony-stimulating factor may improve outcome attributable to neonatal sepsis complicated by neutropenia.
Kocherlakota P; La Gamma EF
Pediatrics; 1997 Jul; 100(1):E6. PubMed ID: 9200380
[TBL] [Abstract][Full Text] [Related]
3. Preliminary report: rhG-CSF may reduce the incidence of neonatal sepsis in prolonged preeclampsia-associated neutropenia.
Kocherlakota P; La Gamma EF
Pediatrics; 1998 Nov; 102(5):1107-11. PubMed ID: 9794941
[TBL] [Abstract][Full Text] [Related]
4. A randomized, controlled trial of prophylactic granulocyte-macrophage colony-stimulating factor in human newborns less than 32 weeks gestation.
Carr R; Modi N; Doré CJ; El-Rifai R; Lindo D
Pediatrics; 1999 Apr; 103(4 Pt 1):796-802. PubMed ID: 10103305
[TBL] [Abstract][Full Text] [Related]
5. G-CSF and GM-CSF for treating or preventing neonatal infections.
Carr R; Modi N; Doré C
Cochrane Database Syst Rev; 2003; 2003(3):CD003066. PubMed ID: 12917944
[TBL] [Abstract][Full Text] [Related]
6. Effect of recombinant human granulocyte colony stimulating factor (rhG-CSF) for the treatment of neonates in presumed sepsis with neutropenia.
Khan TH; Shahidullah M; Mannan MA; Nahar N
Mymensingh Med J; 2012 Jul; 21(3):469-74. PubMed ID: 22828545
[TBL] [Abstract][Full Text] [Related]
7. Recombinant human granulocyte colony-stimulating factor in preterm neonates with sepsis and relative neutropenia: a randomized, single-blind, non-placebo-controlled trial.
Gathwala G; Walia M; Bala H; Singh S
J Trop Pediatr; 2012 Feb; 58(1):12-8. PubMed ID: 21296862
[TBL] [Abstract][Full Text] [Related]
8. A randomized, double-masked, placebo-controlled trial of recombinant granulocyte colony-stimulating factor administration to preterm infants with the clinical diagnosis of early-onset sepsis.
Miura E; Procianoy RS; Bittar C; Miura CS; Miura MS; Mello C; Christensen RD
Pediatrics; 2001 Jan; 107(1):30-5. PubMed ID: 11134430
[TBL] [Abstract][Full Text] [Related]
9. [Hematopoietic growth factors in prevention and therapy of infectious complications in premature and newborn infants].
Lehrnbecher T
Z Geburtshilfe Neonatol; 2001; 205(5):167-73. PubMed ID: 11727663
[TBL] [Abstract][Full Text] [Related]
10. Comparison of recombinant granulocyte colony-stimulating factor, recombinant human granulocyte-macrophage colony-stimulating factor and placebo for treatment of septic preterm infants.
Ahmad A; Laborada G; Bussel J; Nesin M
Pediatr Infect Dis J; 2002 Nov; 21(11):1061-5. PubMed ID: 12442030
[TBL] [Abstract][Full Text] [Related]
11. Results of a phase I/II trial of recombinant human granulocyte-macrophage colony-stimulating factor in very low birthweight neonates: significant induction of circulatory neutrophils, monocytes, platelets, and bone marrow neutrophils.
Cairo MS; Christensen R; Sender LS; Ellis R; Rosenthal J; van de Ven C; Worcester C; Agosti JM
Blood; 1995 Oct; 86(7):2509-15. PubMed ID: 7670096
[TBL] [Abstract][Full Text] [Related]
12. Granulocyte-macrophage colony stimulating factor administered as prophylaxis for reduction of sepsis in extremely preterm, small for gestational age neonates (the PROGRAMS trial): a single-blind, multicentre, randomised controlled trial.
Carr R; Brocklehurst P; Doré CJ; Modi N
Lancet; 2009 Jan; 373(9659):226-33. PubMed ID: 19150703
[TBL] [Abstract][Full Text] [Related]
13. Contrasting effects of recombinant human granulocyte-macrophage colony-stimulating factor (CSF) and granulocyte CSF treatment on the cycling of blood elements in childhood-onset cyclic neutropenia.
Wright DG; Kenney RF; Oette DH; LaRussa VF; Boxer LA; Malech HL
Blood; 1994 Aug; 84(4):1257-67. PubMed ID: 7519479
[TBL] [Abstract][Full Text] [Related]
14. Myeloid colony-stimulating factors: use in the newborn.
Sreenan C; Osiovich H
Arch Pediatr Adolesc Med; 1999 Sep; 153(9):984-8. PubMed ID: 10482217
[TBL] [Abstract][Full Text] [Related]
15. A randomized, placebo-controlled trial of granulocyte colony-stimulating factor administration to newborn infants with neutropenia and clinical signs of early-onset sepsis.
Schibler KR; Osborne KA; Leung LY; Le TV; Baker SI; Thompson DD
Pediatrics; 1998 Jul; 102(1 Pt 1):6-13. PubMed ID: 9651406
[TBL] [Abstract][Full Text] [Related]
16. Recombinant human granulocyte-macrophage colony-stimulating factor accelerates neutrophil and monocyte recovery after allogeneic T-cell-depleted bone marrow transplantation.
De Witte T; Gratwohl A; Van Der Lely N; Bacigalupo A; Stern AC; Speck B; Schattenberg A; Nissen C; Gluckman E; Fibbe WE
Blood; 1992 Mar; 79(5):1359-65. PubMed ID: 1536959
[TBL] [Abstract][Full Text] [Related]
17. Recombinant human granulocyte-macrophage colony-stimulating factor ameliorates zidovudine-induced neutropenia in patients with acquired immunodeficiency syndrome (AIDS)/AIDS-related complex.
Levine JD; Allan JD; Tessitore JH; Falcone N; Galasso F; Israel RJ; Groopman JE
Blood; 1991 Dec; 78(12):3148-54. PubMed ID: 1742482
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the potency of glycosylated and nonglycosylated recombinant human granulocyte colony-stimulating factors in neutropenic and nonneutropenic CD rats.
Nohynek GJ; Plard JP; Wells MY; Zerial A; Roquet F
Cancer Chemother Pharmacol; 1997; 39(3):259-66. PubMed ID: 8996530
[TBL] [Abstract][Full Text] [Related]
19. Treatment of severe neutropenia due to Felty's syndrome or systemic lupus erythematosus with granulocyte colony-stimulating factor.
Hellmich B; Schnabel A; Gross WL
Semin Arthritis Rheum; 1999 Oct; 29(2):82-99. PubMed ID: 10553980
[TBL] [Abstract][Full Text] [Related]
20. Granulocyte macrophage-colony stimulating factor (GM-CSF) in neonatal neutropenia.
Ray M; Mukhopadhyay K; Narang A
Indian J Pediatr; 2000 Jan; 67(1):67-8. PubMed ID: 10832225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
